General Hill (ret) James T. - Net Worth and Insider Trading

General Hill (ret) James T. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, General Hill (ret) James T. owns 1 companies in total, including iBio Inc (IBIO) .

Click here to see the complete history of General Hill (ret) James T.’s form 4 insider trades.

Insider Ownership Summary of General Hill (ret) James T.

Ticker	Comapny	Transaction Date	Type of Owner
IBIO	iBio Inc	2010-08-16	director

General Hill (ret) James T. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

General Hill (ret) James T. Ownership Network

Ownership Network List of General Hill (ret) James T.

No Data

Ownership Network Relation of General Hill (ret) James T.

General Hill (ret) James T. Owned Company Details

What does iBio Inc do?

Who are the key executives at iBio Inc?

General Hill (ret) James T. is the director of iBio Inc. Other key executives at iBio Inc include Chief Scientific Officer Martin Brenner , Interim CFO Felipe Duran , and director & CEO and Executive Chairman Isett Thomas Francis 3rd .

iBio Inc (IBIO) Insider Trades Summary

Over the past 18 months, General Hill (ret) James T. made no insider transaction in iBio Inc (IBIO). Other recent insider transactions involving iBio Inc (IBIO) include a net sale of 84,655 shares made by Martin Brenner ,

In summary, during the past 3 months, insiders sold 0 shares of iBio Inc (IBIO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,233 shares of iBio Inc (IBIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,233 shares.

iBio Inc (IBIO)'s detailed insider trading history can be found in Insider Trading Tracker table.

iBio Inc Insider Transactions

No Available Data

General Hill (ret) James T. Mailing Address

Above is the net worth, insider trading, and ownership report for General Hill (ret) James T.. You might contact General Hill (ret) James T. via mailing address: C/o Ibiopharma, Inc., 9 Innovation Way, Suite 100, Newark De 19711.

Discussions on General Hill (ret) James T.

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.